PsiloThera, Inc.

Psychedelic Healthcare Innovation

Security Type
Common Stock
Min Investment
Offering Date
July 29, 2021
Expected Close Date
March 18, 2022
Amount Raised
Target Raise
No. Investors
Security Price

Company Description

Psilothera is a pioneering mental health care company dedicated to creative, modern solutions to treat global healthcare concerns, including depression, anxiety, PTSD, eating disorders, addictions, Alzheimer’s, dementia, and more. We plan to deploy quantum technology to shorten the drug development time, which will give us an advantage over our competitors. With a focus on healing, hope, and compassion, we aim to change the paradigm of mental healthcare with their Psilocybin-based therapies.


StartEngine OWNERS Exclusive Click here to learn more

$500+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$50,000+ Investment
Tier 1: $50,000+ Invest $50,000 or more and receive 5% bonus shares

$75,000+ Investment
Tier 2: $75,000+ Invest $75,000 or more and receive 7% bonus shares

$100,000+ Investment
Tier 3: $100,000+ Invest $100,000 or more and receive 10% bonus shares

Key Deal Facts

Psilothera is stepping into the scene of major healthcare crisis by focusing on medical research breakthroughs and groundbreaking legalizations
The company is actively targeting a $100 billion market opportunity in Psilocybin healthcare
Psilothera is led by a battle tested management team with business model, strategy and plan driven by research and development

Security Description

Common stock is a security that represents ownership in a corporation.

Research Reports

No reports have been submitted

Become a Reporter